SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons

Neurotoxicity Research
Erkan KirisSina Bavari

Abstract

Botulinum neurotoxins (BoNTs), the causative agents of botulism, are potent inhibitors of neurotransmitter release from motor neurons. There are currently no drugs to treat BoNT intoxication after the onset of the disease symptoms. In this study, we explored how modulation of key host pathways affects the process of BoNT intoxication in human motor neurons, focusing on Src family kinase (SFK) signaling. Motor neurons derived from human embryonic stem (hES) cells were treated with a panel of SFK inhibitors and intoxicated with BoNT serotypes A, B, or E (which are responsible for >95 % of human botulism cases). Subsequently, it was found that bosutinib, dasatinib, KX2-391, PP1, PP2, Src inhibitor-1, and SU6656 significantly antagonized all three of the serotypes. Furthermore, the data indicated that the treatment of hES-derived motor neurons with multiple SFK inhibitors increased the antagonistic effect synergistically. Mechanistically, the small molecules appear to inhibit BoNTs by targeting host pathways necessary for intoxication and not by directly inhibiting the toxins' proteolytic activity. Importantly, the identified inhibitors are all well-studied with some in clinical trials while others are FDA-approved drugs. Overall, ...Continue Reading

References

Aug 2, 1996·The Journal of Biological Chemistry·A V Ferrer-MontielM Montal
Mar 1, 1997·Toxicon : Official Journal of the International Society on Toxinology·S S DeshpandeM Adler
Jul 10, 1998·FEBS Letters·J A EncinarA Ferrer-Montiel
Dec 14, 1999·Journal of Applied Toxicology : JAT·J P AplandM G Filbert
Mar 7, 2001·JAMA : the Journal of the American Medical Association·S S ArnonUNKNOWN Working Group on Civilian Biodefense
Jan 14, 2004·Biochemistry·James E KellerElaine A Neale
Mar 23, 2004·Nature Reviews. Neuroscience·Michael W Salter, Lorraine V Kalia
Oct 23, 2004·Emerging Infectious Diseases·Jeremy SobelSusan Maslanka
Dec 8, 2004·FEBS Letters·Cristina IbañezAntonio Ferrer-Montiel
Dec 14, 2004·Nature·Mark A Breidenbach, Axel T Brunger
May 24, 2005·Current Opinion in Pharmacology·Cesare Montecucco, Jordi Molgó
Jun 30, 2005·Proceedings of the National Academy of Sciences of the United States of America·Lawrence M Wein, Yifan Liu
Mar 18, 2006·Science·Min DongEdwin R Chapman
May 9, 2006·Cell Biochemistry and Biophysics·Deborah A SnyderDixon J Woodbury
Jan 4, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yilong ShuKevin D Gillis
Apr 22, 2008·Cellular and Molecular Life Sciences : CMLS·A T BrungerM A Breidenbach
May 31, 2008·The Journal of Biological Chemistry·Stefan SikorraThomas Binz
Sep 26, 2008·Molecular Biology of the Cell·Min DongEdwin R Chapman
Jan 24, 2009·Proceedings of the National Academy of Sciences of the United States of America·Audrey FischerMauricio Montal
Apr 18, 2009·The Journal of Pharmacology and Experimental Therapeutics·Julie A Coffield, Xiuzhen Yan
Apr 28, 2009·Current Opinion in Pharmacology·J Oliver DollySaak V Ovsepian
May 1, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tzu-Jen KaoArtur Kania
Jul 8, 2009·Nature Biotechnology·Joseph LehárAlexis A Borisy
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·C Geoffrey LauR Suzanne Zukin
Feb 18, 2010·Journal of the American Chemical Society·Peter SilhárKim D Janda
Mar 6, 2010·Trends in Microbiology·Ramin Mollaaghababa HakamiSina Bavari
Jun 10, 2010·Journal of Cell Science·Mirko MessaFabio Benfenati
Aug 7, 2010·Neoplasia : an International Journal for Oncology Research·Alexey Aleshin, Richard S Finn
Jan 5, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Bing LiTerry L Bowlin
Jan 11, 2011·Biochemical and Biophysical Research Communications·Patrick McNuttMariano Mesngon
Mar 8, 2011·The Journal of Biological Chemistry·Sheng Chen, Joseph T Barbieri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.